Schedule 13G ownership disclosure

ASCENDIS PHARMA A/S

American Depositary Shares · CUSIP: 04351P101

Event date: 2025-09-30

Filing-level shares
4,323,059
Percent of class
7.8%
  • JANUS HENDERSON GROUP PLC

    Shares: 4,323,059 · Class: 7.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001274173-25-000281
Form type
SCHEDULE 13G/A
Filer
Ascendis Pharma A/S
CIK
CIK 1612042
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub